(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
@ $135.80
Issued: 19 Apr 2024 @ 11:00
Return: -0.76%
Previous signal: Apr 19 - 09:53
Previous signal:
Return: -1.06 %
Live Chart Being Loaded With Signals
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry...
Stats | |
---|---|
Today's Volume | 352 906 |
Average Volume | 541 700 |
Market Cap | 7.13B |
EPS | $0 ( 2024-02-27 ) |
Next earnings date | ( $0.710 ) 2024-05-14 |
Last Dividend | $1.000 ( 2012-11-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 89.25 |
ATR14 | $3.72 (2.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Tripodi Blair | Buy | 30 000 | Restricted Stock Units |
2024-03-01 | Tripodi Blair | Buy | 9 127 | Non-Qualified Stock Option (Right to Buy) |
2024-03-01 | Muhsin Bilal | Buy | 30 000 | Restricted Stock Units |
2024-02-28 | Muhsin Bilal | Buy | 2 010 | Common Stock |
2024-02-28 | Muhsin Bilal | Sell | 745 | Common Stock |
INSIDER POWER |
---|
77.80 |
Last 93 transactions |
Buy: 793 924 | Sell: 148 839 |
Volume Correlation
Masimo Corp Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Masimo Corp Correlation - Currency/Commodity
Masimo Corp Financials
Annual | 2023 |
Revenue: | $2.05B |
Gross Profit: | $1.00B (49.00 %) |
EPS: | $1.540 |
Q4 | 2023 |
Revenue: | $548.90M |
Gross Profit: | $262.70M (47.86 %) |
EPS: | $0.640 |
Q3 | 2023 |
Revenue: | $478.90M |
Gross Profit: | $234.80M (49.03 %) |
EPS: | $0.200 |
Q2 | 2023 |
Revenue: | $455.30M |
Gross Profit: | $221.20M (48.58 %) |
EPS: | $0.300 |
Financial Reports:
No articles found.
Masimo Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.00 | 2010-03-09 |
Last Dividend | $1.000 | 2012-11-23 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-11 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $3.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.19 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 2.69 | |
Div. Directional Score | 6.52 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $2.75 | 9.24% |
2011 | $0 | 0.00% |
2012 | $1.000 | 5.31% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0398 | 1.500 | 9.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0268 | 1.200 | 9.11 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0618 | 1.500 | -0.425 | -0.637 | [0.1 - 1] |
payoutRatioTTM | 0.156 | -1.000 | 8.44 | -8.44 | [0 - 1] |
currentRatioTTM | 2.18 | 0.800 | 4.08 | 3.26 | [1 - 3] |
quickRatioTTM | 1.041 | 0.800 | 8.58 | 6.87 | [0.8 - 2.5] |
cashRatioTTM | 0.294 | 1.500 | 9.48 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.304 | -1.500 | 4.94 | -7.40 | [0 - 0.6] |
interestCoverageTTM | 3.14 | 1.000 | 9.95 | 9.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.677 | -1.500 | 7.29 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.490 | 1.000 | 5.17 | 5.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0769 | 1.000 | -0.463 | -0.463 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.102 | 1.000 | -0.545 | -0.545 | [0.2 - 2] |
assetTurnoverTTM | 0.673 | 0.800 | 8.84 | 7.08 | [0.5 - 2] |
Total Score | 10.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 92.53 | 1.000 | 0.755 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0618 | 2.50 | -0.273 | -0.637 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.156 | 1.500 | 8.44 | -8.44 | [0 - 1] |
pegRatioTTM | 0.322 | 1.500 | -1.189 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0459 | 1.000 | -1.351 | 0 | [0.1 - 0.5] |
Total Score | 2.69 |
Masimo Corp
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators